Kostenis, Evi
Universität Bonn,
Germany
2025 Rank: 127641
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 903 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127641 | 114694 |
| Total Cites | 688 | 849 |
| H-index | 11 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 48 | 48 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 242 | 291 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 574 | 652 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.30 |
| Self-Citation Percentage |
18.96%
|
|
Kostenis, Evi
Universität Bonn,
Germany
2024 Rank: 126183
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 856 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126183 | 107887 |
| Total Cites | 654 | 796 |
| H-index | 12 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 47 | 49 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 221 | 259 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 536 | 600 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.33 |
| Self-Citation Percentage |
17.84%
|
|
Kostenis, Evi
Universität Bonn,
Germany
2023 Rank: 116687
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 799 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 116687 | 101149 |
| Total Cites | 664 | 814 |
| H-index | 11 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 40 | 42 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 243 | 301 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 533 | 612 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.33 |
| Self-Citation Percentage |
18.43%
|
|
Kostenis, Evi
Universität Bonn,
Germany
2022 Rank: 79837
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 522 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79837 | 70220 |
| Total Cites | 689 | 887 |
| H-index | 12 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 60 | 66 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 270 | 345 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 538 | 615 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.44 |
| Self-Citation Percentage |
22.32%
|
|
Kostenis, Evi
Universität Bonn,
Germany
2021 Rank: 85576
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 556 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85576 | 75114 |
| Total Cites | 985 | 1264 |
| H-index | 14 | 16 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 86 | 91 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 411 | 515 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 766 | 874 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.45 |
| Self-Citation Percentage |
22.07%
|
|
Kostenis, Evi
Universität Bonn,
Germany
2020 Rank: 85816
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 526 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85816 | 77017 |
| Total Cites | 722 | 907 |
| H-index | 11 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 65 | 67 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 301 | 357 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 555 | 653 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.39 |
| Self-Citation Percentage |
20.40%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.